Navigation Links
Aurobindo Gets USFDA Approval for Didanosine Chewable Tablets

Aurobindo Pharma Ltd today said it has received tentative approval by USFDA for its anti-HIV drug, Didanosine chewable tablets of 100mg, 150mg and 200mg strengths. //

This is the first generic version approval for Didanosine chewable in the world given by USFDA, Aurobindo Pharma informed the Bombay Stock Exchange.

The aforesaid product would now be available for purchase under the President's Emergency Plan for AIDS Relief (PEPFAR), it added.

The company manufactures both Active Pharmaceutical Ingredients (API) and formulation for this generic version and with this approval, the antiretroviral (ARV) product portfolio of the company increased to 17.

Didanosine is a Nucleoside reverse transcriptase inhibitor (NRTI) class of drugs, and a key component of the ARV regimens in various parts of the world. This molecule enjoys approximately USD 100 mio of market share, it said.

The drug helps prevent AIDS virus from reproducing. It is used in combination with other antiretroviral agents for the treatment of HIV-1 infection. It is the version of VIDEX an anti-HIV medication manufactured by Bristol Myers Squibb.

The shares of the company was trading at Rs 608, up 2.16 per cent at the BSE.

Source:PTI News
'"/>




Page: 1

Related medicine news :

1. Aurobindo gets U.S. FDA approval for Cephalexin
2. US FDA approved Aurobindo Pharma to produce generic AIDS drug
3. Aurobindo Receives Approval from USFDA for anti-AIDS drug
4. Aurobindo Gets Tentative USFDA Approval For Its HIV-1 Drug
5. Aurobindo Pharma Purchases US Manufacturing Facility
6. Aurobindo Gets USFDA Approval for A 3-Drug Combination Pack
7. Morepan to file new drug applications with the USFDA
8. Ranbaxy Gets USFDA Approval For Doxycycline Tablets
9. Cadila Gets Tentative USFDA Nod For Pravastatin Sodium Tablets
10. Lupin Gets USFDA Approval For Quinapril Tablets
11. Ranbaxy Gets USFDA Nod For Simvastatin
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/26/2016)... ... June 27, 2016 , ... Quality metrics are proliferating in cancer care, and ... in the eye of the beholder, according to experts who offered insights and commentary ... of Managed Care. For the full issue, click here . , For the ...
(Date:6/26/2016)... ... June 26, 2016 , ... Many women are ... with endometriosis. These women need a treatment plan to not only alleviate symptoms ... can help for preservation of fertility and ultimately achieving a pregnancy. The specialists ...
(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency Room , the largest ... as the Medical Director of its new Mesquite-Samuell Farm facility. , “We are ... Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director of First Choice Emergency ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article published ... unfamiliar with. The article goes on to state that individuals are now more comfortable ... less common operations such as calf and cheek reduction. The Los Angeles area medical ...
(Date:6/24/2016)... ... June 24, 2016 , ... Global law firm Greenberg Traurig, P.A. announced that ... chosen by their peers for this recognition are considered among the top 2 percent ... special honors as members of this year’s Legal Elite Hall of Fame: Miami ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... 24, 2016  Arkis BioSciences, a leading innovator ... more durable cerebrospinal fluid treatments, today announced it ... funding is led by Innova Memphis, followed by ... private investors.  Arkis, new financing will accelerate the ... market release of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... DUBLIN , June 23, 2016 ... "Dialysis Devices Global Market - Forecast to 2022" report ... is the treatment method for the patients with kidney failure, ... and excess fluid from the patient,s blood and thus the ... sodium, potassium and chloride in balance. Increasing ...
(Date:6/23/2016)... 23, 2016 Research and Markets ... Market by Type (Organic Chemical (Sugar, Petrochemical, Glycerin), Inorganic ... Coating, Parenteral) - Global Forecast to 2021" report ... The global pharmaceutical excipients market is projected to ... of 6.1% in the forecast period 2016 to 2021. ...
Breaking Medicine Technology: